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Introduction
Several systems have been described to co-express two or more genes; splicing, internal promoters, internal ribosome entry sites (IRES), fusion proteins, etc. All these systems are being used by different wild-type viruses and have been introduced by genetic engineering in retrovirus and other contexts for various applications. 1 Nevertheless, there remain several other viral mechanisms, not yet exploited by genetic engineering, that could be used in the construction of viral vectors. In this article, we describe a strategy based on the incorporation of the 2A sequence from FMDV.
Picornaviruses have a single-stranded RNA genome 7.5-8.5 kb long. The viral RNA has an oligopeptide (Vpg or 3B) covalently attached to the 5Ј terminus. The genome is organised into three regions: (1) a long 5Ј non-coding region; (2) a single, long open reading frame encoding a polyprotein of some 225 kDa; and (3) a short 3Ј noncoding region with a poly(A) tail. Picornavirus polyproteins undergo co-translational cleavages to produce the primary processing products P1, P2, P3. [2] [3] [4] Subsequent proteolytic processing of these precursors gives rise to the 'mature' proteins ( Figure 1a ). The position of picornavirus proteins within the polyprotein is indicated by the domain (1, 2 or 3) and by the position within the individual domain (A, B, C or D).
In the case of two major genera of the picornaviruses, the enterovirus and rhinoviruses, 2A is a proteinase that cleaves at its own N-terminus. In this way, the P1 (capsid proteins) and P2 (replicative proteins) regions of the polyprotein are separated by processing at the 1D/2A site. The 2A proteinase (2A pro ) is also able to cleave the p220 cellular component (also called eIF-4G) from the cap-binding complex (eIF-4F) used in the translation of the vast majority of 'capped' cellular mRNAs. This p220 breakdown results in the 'shut-off' of host cell protein synthesis. Initiation of translation of the viral RNA on the other hand is directed by the IRES (Figure 1a ) and, therefore, is not inhibited by the p220 cleavage.
In contrast, in the cardio-and aphthoviruses the cleavage site between the capsid protein and replicative protein regions occurs at the 2A/2B junction. The cardiovirus 2A region is about 140 amino acids long whilst aphthovirus 2A is only 18 amino acids long. The Nterminal end of cardiovirus 2A is dispensable and its function is unknown. [5] [6] [7] The C-terminal region of cardiovirus 2A is, however, highly similar to the (shorter) aphthovirus 2A. In this region, the last three residues of 2A (Asn-Pro-Gly) and the N-terminal residue of 2B (Pro) are completely conserved as part of the consensus octamer Asp-Val/Ile-Glu-X-Asn-Pro-Gly and Pro. 3 This sequence is extremely rare within current databases, the only examples are from cardiovirus, aphthovirus and group C porcine rotaviruses and is always associated with a 'cleavage' activity. 8 Mutations in this sequence for EMCV (encephalomyocarditis virus) impair cleavage at the glycyl-prolyl site. 5, 8 There are several theories to explain aphto and cardiovirus 2A-mediated cleavage. 3, 4 The first proposes that 2A could be an entirely novel oligopeptide autoproteinase. The second that 2A could be the target for an unknown cellular proteinase (whose activity should be tightly coupled to translation); and thirdly that aphtho-and cardiovirus 2A could function by impairing the normal peptide bond formation, although allowing translation to proceed. 4 Many observations support the latter hypothesis -in particular an over-accumulation of the translation product N-terminal of 2A with respect to the C-terminal of 2A (not due to differential protein degradation rates; Donnelly MLL, Gani D and Ryan MD, personal comunication). This hypothesis proposes ribosomes may either continue translation, or dissociate at the 2A region such that lower levels of downstream translation products are synthesized. Aphthoviruses seem to contain the minimum length of 2A region necessary for this 'cleavage'. In FMDV, the protease that induces cleavage of p220 is the leader protein (L pro ; Figure 1a ) and not 2A, as is the case for enterovirus and rhinovirus. 9, 10 The small 2A region has been used successfully in heterologous contexts, 11 obtaining Ͼ80% cleavage activity in rabbit reticulocyte lysate when this region was cloned between the reporter genes cat (cholramphenicol acetyltransferase) and gus (␤-glucuronidase). 2A-mediated cleavage was demonstrated in human HTK-143 cells. 11 Using similar constructions (Figure 1b ), other authors 6 obtained 85% cleavage between cat and gus after introducing FMDV 2A (19 amino acids, Figure 1c) . The percentage could be increased to 99% when the fragment FMDV 2A also included the 39 amino acids at the C-terminal end of 1D (Figure 1d ). These cleavages were not detected in equivalent constructions expressed in E. coli, showing 'cleavage' specificity for eukaryotic systems alone. 6 FMDV 2A
cleavage activity was also used in the construction of recombinant influenza virus (17 amino acid insertion) 12 and foamy virus (14 amino acid insertion). 13 FMDV 2A cleavage activity was detected when these viruses were introduced in Madin-Darby bovine kidney cells (MDBK) 12 and baby hamster kidney cells (BHK-21), 13 respectively. In this article, we describe the construction of a new kind of bicistronic retroviral vector using the 2A region of FMDV. It represents an alternative to systems currently used for co-expression of two proteins in retroviral vectors. In the present procedure, two genes are cloned to flank the 2A sequence forming a single open reading frame. The cleavage of the polyprotein product takes place at the C-terminal end of the 2A region, leaving this peptide fused to the upstream protein and releasing the downstream protein intact (with the addition of a Nterminal Pro).
We also describe a new chimeric gene in which the expression of a dominant positive puromycin selectable marker gene pac (puromycin N-acetyl transferase) is 200 fused in-frame with the dominant negative ganciclovir (GCV) selection gene HSV1tk (herpes simplex virus type 1 thymidine kinase).
Results
Construction of 2A-containing retroviral vectors Plasmids pMD2 (containing the FMDV 2A region between the cat and gus genes) and pTG394 (containing a ⌬1D2A insert) were used as starting points for subsequent molecular biological manipulations (Figure 1b-d) . 6 The cat gene was substituted by the 3Ј end of pac amplified by PCR (and removing the stop codon) to obtain pMD2pac and pTG394pac (Figure 2a ). From these plasmids and the vector pLPIT (Figure 2b Expression of the gene upstream of 2A or ⌬1D2A, in retroviral producer cells Murine ecotropic retroviral packaging cells ⌿CRE were transfected and their supernatants were used to infect amphotropic retroviral packaging cells ⌿CRIP.
14 Transfection efficiencies were similar in all cases (Table 1) .
Transfected and infected retroviral producer cells were selected by growing them in 2 g/ml of puromycin for about 3 weeks. All cells grew well despite the C-terminal extension of 2A or ⌬1D2A to the PAC protein. The same effect was observed when estimating the titer of supernatants harvested from producer cells by infection of NIH/3T3 and cultured in 2 g/ml puromycin. Titers from ⌿CRE transfected cells were clearly lower (in the range of 0.5-1.3 × 10 4 colony forming units/ml), than titers of ⌿CRIP infected cells (ranging from 1.2 to 3.4 × 10 6 c.f.u./ml) ( Table 1) . ⌿CRE titers were similar in all cases except those derived from bicistronic vectors which always produced lower values than the others. In general we can confirm that transfected cells have lower titers than infected cells. 14 We have also observed that ⌿CRE cells have more difficulty in reaching confluence than ⌿CRIP cells. ⌿CRIP titers were well within the range of normal values using retroviral vectors. LPIT and LTSP showed lower titers (about half) than the monocistronic control LPX. Bicistronic and putative tricistronic vectors with 2A or ⌬1D2A showed similar values to LPX (except for LP-⌬1D2A-XIT with a little lower value). Supernatant derived from the fusion LPT also showed a high titer.
Expression of the genes cloned downstream from 2A or ⌬1D2A HSV1tk expression was estimated by GCV sensitivity in the different cell lines. In transfected ⌿CRE producer cells, the concentration at which 50% of the cells die (IC 50 ) was, in all cases, lower than 1 g/ml (Figure 3a) . Bicistronic and putative tricistronic vectors with 2A or ⌬1D2A showed good sensitivities to GCV, in a range similar to that observed for the LPIT and LTSP control vectors; bicistronic vectors showing slightly better results than putative tricistronics. ⌿CRE cells transfected with the fusion LPT also showed a good sensitivity. The GCV sensitivity of infected ⌿CRIP producer cells was also determined (Figure 3b) . The results were similar to those obtained previously, however, an improvement from transfected ⌿CRE cells can be observed. All bicistronic and putative tricistronic vectors with 2A or ⌬1D2A showed good GCV sensitivities -similar to the positive controls. Again, bicistronic constructions were slightly better (IC 50 from LP-2A-T is 5 × 10 −2 g/ml and from LP-⌬1D2A-T, 7 × 10 −2 ) than putative tricistronic (IC 50 : 13 × 10 −2 g/ml for both LP-2A-XIT and LP-⌬1D2A-XIT) and the fusion LPT gave high drug sensitivity (IC 50 : 2 × 10 −1 g/ml). In order to obtain a better approximation of 2A and ⌬1D2A cleavage efficiency, we analyzed the protein products derived from these vectors using antibodies against HSV1TK by Western blotting (Figure 4a) . In LPIT and LTSP we detected a single HSV1TK band migrating at the same position and with similar intensity (lanes 2 and 3). In the LPIT vector (lane 2) and the putative tricistronic (lanes 4 and 5), HSV1TK translated from the IRES (originally from EMCV) whilst LTSP vector (lane 3) uses the 5Ј long terminal repeat (LTR) for initiation of transcription. The same HSV1TK protein band, migrating at the same position is observed in the case of the bicistronic vectors (lanes 6 and 7). We concluded therefore, that the 2A and ⌬1D2A sequences efficiently 'cleave' the artificial polyprotein. The high molecular weight HSV1TK-2A/⌬1D2A-PAC fusion protein could not be detected from these constructs. There is a non-specific band that can be seen also in the negative control with LPX vector infected cells (lane 1) in a position close to, but migrating slightly slower than, the PAC-HSV1TK fusion protein (lane 8). The weaker HSV1TK band in lane 8 could be explained by a slight instability of fusion protein and, perhaps, by the method of sample preparation before Western blotting.
In the tricistronic vector in wich EGFP is placed after ⌬1D2A, we were able to detect green fluorescence in a significant number of cells, when a lawn of ⌿CRIP-infected cells (selected for 1 month in 2 g/ml puromycin) was subjected to flow cytometry (Figure 4b ). This shows that both PAC and EGFP proteins are expressed from this construct.
Behavior of retroviral producer cells after long-term culture in selective medium The present study was completed with long-term culture of the producer cells in order to determine whether the new retroviral constructs retained the original titer and drug sensitivity. ⌿CRIP/LP-2A-T, ⌿CRIP/LPIT and ⌿CRIP/LTSP producer cells were cultured under con- tinuous selection with 2 or 10 g/ml of puromycin. After 2 months selection in 2 g/ml puromycin (from initial transfection-infection), cultures were divided in two parts. One part was maintained at the same selection concentration while the other half was increased to 10 g/ml puromycin. After 1 more month, titration of producer cells was repeated (except for ⌿CRIP/LTSP which, due to slow growth, was left for 2 additional weeks before supernatants were harvested) and GCV sensitivity determined. The data presented in Table 2 shows that long-term culture (about 3 months) in 2 g/ml puromycin can be correlated with a general maintenance of all titers measured, which remained close to 10 6 c.f.u./ml. Increasing puromycin selection (10 g/ml) in the third month led to titers similar to those obtained previously from bicistronic vectors (with 2A or IRES), whilst LTSP retrovirus producer cells reduced in titer about one log unit (10 5 c.f.u./ml) from the initial value.
Three months culture in 2 g/ml puromycin resulted, however, in a small decrease of GCV sensitivity (LP-2A-T: the IC 50 increases from 5 × 10 −2 to 10 × 10 −2 g/ml; LPIT: from 13 × 10 −2 to 26 × 10 −2 g/ml), except for the LTSP vector where the effect was more marked (with increments of the IC 50 from 6 × 10 −2 to 230 × 10 −2 g/ml; Figure 5 ). When selection was increased to 10 g/ml of puromycin in the last month, GCV sensitivity was maintained at the previously observed values (IC 50 LP-2A-T: 5 × 10 −2 g/ml; LPIT: 6 × 10 −2 g/ml). In the case of the LTSP producer cells, however, the improvement did not reach the initial IC 50 value (40 × 10 −2 g/ml). Figure 5 shows that whilst 2A or IRES bicistronic retrovirus producer cells behaved similarly in long-term culture (they lost GCV sensitivity with 2 g/ml puromycin and recovered it with 10 g/ml), the LTSP retrovirus producer cells (with an internal promoter directing pac gene expression) increased their IC 50 by more than a half logarithmic unit despite increase of puromycin selection. These results suggest that vectors having IRES or 2A maintain higher titer and better sensitivity to the drug, than vectors with internal promoters.
Vector expression in human glioma cells Hs 683
In vectors that may be used for gene therapy of cancer cells, it is interesting to know whether tumoral cells can be efficiently infected as NIH/3T3 derived cells, and whether in vivo situations (infection but no selection) is relatively similar to cell culture conditions in which selection generally precedes gene expression estimates.
⌿CRIP supernatants (LP-2A-T, LP-⌬1D2A-T, LTSP and LPIT harvested after 1 month in 2 g/ml puromycin selection) were used to infect the Hs 683 human glioma cell line.
GCV sensitivity, using retrovirus-infected Hs 683 cells, was determined 3 days after infection in the absence of puromycin selection (Figure 6a) . A lawn of Hs 683 cells (a mixture of infected and uninfected cells) was cultured for 72 h with GCV. In spite of this, the observed IC 50 was lower than 1 g/ml. Note that cells had been cultured in the presence of GCV 1 day more than in other assays since in only 48 h, cell mortality was not so marked. The results do not exclude a component related to infection efficiency.
In parallel experiments, Hs 683-infected cells selected with 2 g/ml puromycin for 10 days showed significant Table 2 ). 2P, 3 months with 2 g/ml puromycin selection; 10P, 2 months with 2 g/ml puromycin selection and 1 month with 10 g/ml puromycin selection. Assay conditions are the same as in Figure 3 .
Figure 5 Sensitivity to GCV, as a percentage of cell survival, for ⌿CRIP retroviral producer cell populations infected with LP-2A-T, LTSP and LPIT vectors after 3 months of culture in different selective conditions (see also
GCV sensitivity after 48 h incubation (Figure 6b) . A lower IC 50 value has been obtained without puromycin ( Figure  6a ) than with the selection (Figure 6b ) provided the drug (GCV) is kept for 24 h longer in the culture. Nevertheless, their IC 50 is not as low as that of ⌿CRE or ⌿CRIP producer cells (Figure 3a and b) . We believe the variations observed reflect the different origins of the cell lines.
Discussion
Retroviral vectors to be used in gene therapy must ensure an efficient expression of therapeutic genes, as well as selection markers. When different internal promoters are placed in these vectors, interference among them may cause inactivation of some of the exogenous genes. The presence of an IRES, instead of a second promoter, is a well known and widely used alternative for the coexpression of two genes. We have constructed these two types of retroviral vectors using the selectable marker pac and the potential killer suicide HSV1tk gene (Figure 2b and g). Both constructions produced viruses to high titers and GCV sensitivities (Table 1, Figure 3) . A third possibility would be to make a hybrid gene with no separation between the two coding regions, that will give a single protein with a combined activity. Here we have fused pac and HSV1tk to obtain a positive and negative selection protein. This fusion contained the complete sequence of both genes (Figure 2e ). Because pac gene is smaller (0.6 kb) than other selection genes: neo (neomycin phosphotransferase) 0.8 kb and hph (hygromycin B phosphotransferase) 1 kb, this fusion protein is smaller than those previously described: HSV1tk-neo, 15, 16 hph-HSV1tk. 17 The risk with these types of constructs is a lack of efficiency in one or both functions due to structural changes, or to different cellular location from which one or both gene products normally operate. In our fusion protein, the pac domain is functional and we only see a small decrease in GCV sensitivity (Table 1, Figure 3 ). In our particular case, the cellular location of the expressed protein is not a problem since both proteins are normally located in the cytoplasm. The expression of membranous or extracellular proteins, however, might prove more difficult with such fusion proteins.
The new alternative system we describe here is based on the introduction of the 2A small region from FMDV in phase between pac and HSV1tk genes or between pac and egfp in the context of a widely used defective retroviral vector derived from Moloney murine leukemia virus (Figure 2) . Previous viral constructions carrying 2A sequence showed the utility of this small region to cleavage a polyprotein. 12, 13 In each case, the recombinant viral genomes had the marker cat gene linked to another gene via 2A. In the case of the influenza virus construct, the CAT-2A cassette was inserted N-terminal of the neuraminidase to form a single CAT2ANA open reading frame (the 2A fragment used comprises 17 amino acids). 12 In the other study, 2A-CAT was inserted C-terminal of Bel-1 in foamy virus again forming a single open reading frame. In this virus, a small region of non-essential genes was deleted to accommodate the insert. The FMDV 2A sequence used here was smaller (only 14 amino acids) than that used in the construction of the bicistronic influenza virus RNA segment.
The 96 nucleotide insert encoding the 2A region (54 nucleotides plus the codon for the N-terminal proline of 2B; Figure 1c) or the 201 nucleotide insert carrying the ⌬1D2A (Figure 1d ) is shorter than the SV40 early promoter (343 nucleotides) used in a variety of retroviral vectors. 18 Even the IRES, widely used in bicistronic vectors has a minimal sequence of 422 (poliovirus) or 426 (EMCV) nucleotides. 2 The inserts carrying the IRES sequences usually have an addition of 634 nucleotides (pSBC-1) 19 or 513 nucleotides (pSXLC-TK used in this study). 20 In vectors such as retrovirus where the coding capacity to express therapeutic genes is not very large (7-8 kb), a small sequence such as 2A could be preferable to other alternatives. Some caution should be employed when using the 2A system. The two cloned genes must be in a single open reading frame (eliminating the stop codon from the end of the first gene). Additionally, following cleavage the 2A peptide remains attached to the first gene product as a C-terminal extension. This has not been a limitation for the activity of the attached gene product PAC (Tables 1  and 2 ), or to other gene products such as CAT or GUS (data not shown). It should be noted that the second gene will posses an N-terminal proline residue. In our constructions a sequence coding for several restriction enzyme target sites was present at the 5Ј end of this second (downstream of 2A) gene. Nevertheless, activities of HSV1tk (Figures 3 and 5) or EGFP ( Figure 4b) were not affected by these additional sequences. One of the advantages of this bicistronic system is to obtain two discrete protein products (similar to the IRES system). This may be of paramount importance if the proteins have different cellular localizations, a disadvantage of the fusion protein strategy. We have show that our 2A-containing vectors direct the synthesis of independent products (Figure 4a) .
It is possible to generate a small amount of fused protein that may or may not conserve the activity of one or both proteins. In vitro studies have estimated a cleavage of Ͼ85% for 2A and 99% for ⌬1D2A. 6 We have compared the presence and activity of pac and HSV1tk when placed before and after both the short (2A) or long (⌬1D2A) 2A sequences and found no significant differences. The results are also comparable to the activities obtained for 206 these gene products (pac and HSV1tk) using the SV40 internal promoter or the IRES from the EMCV (Table 1 and Figure 3) .
The design of effective retroviral vectors and their possible use in vivo requires provirus stability. There are several factors affecting long-term functional and structural stability such as the nature of the infected cells, the integration site of the provirus, the reporter gene and the presence or absence of selection pressure. Activity of HSV1tk was long-term maintained for at least 3 months (in the presence of puromycin selection) but we have observed that the presence of an internal promoter before the selection gene (probably valid also for the reporter gene) is likely to producer a higher instability than the presence of 2A or IRES (Table 2, Figure 5 ).
The 2A system does not work in E. coli, 6 but it works well in eukaryotic cell culture from organisms as diverse as insects (Spodoptera frugiperda) 21 or mammalian cell lines (HTK-143, 11 MDBK, 12 BHK-21 13 ). In this work we have demonstrated the correct functioning of the 2A system in other mammalian cells (⌿CRE, ⌿CRIP, NIH/3T3), including human glioma cell line Hs 683 ( Figure 6 ).
The small and efficient 2A sequence can be used in combination with an IRES for the construction of tricistronic vectors eliminating the need for internal promoters that may interfere with the potent LTR initial promoter (eg LP-⌬1D2A-GIT; Figure 2c ). Two different IRESs (one from ECMV and the other from poliovirus) can also be used to reduce the chance of putative recombination that could get rid of the internal gene; nevertheless it has been shown that two IRESs close together may cause a decrease in the expression of the coupled genes. 22 The 2A system appears to be a useful complement or alternative to an IRES in the construction of bicistronic or higher order cistronic vectors. The vectors we describe here could be useful as an alternative in gene therapy constructs, especially tricistronic systems for the expression of heterodimeric proteins, such as certain cytokines. 23 Improvements in the design of retroviral vectors similar to the ones we propose here, offer the possibility to improve the efficiency of gene therapies.
Materials and methods

Construction of recombinant plasmids
The backbone of all retroviral plasmids was taken from pBabepuro.
18 HSV1tk and IRES sequences were obtained from pSXLC-TK 20 and FMDV sequences from plasmids pMD2 and pTG394. 6 Plasmid pMD2 contains the FMDV 2A sequence inserted between the cat and gus genes, and plasmid pTG394 contains ⌬1D2A insert in the same position (Figure 1b-d) . Regions 2A and ⌬1D2A are delimited by XbaI and ApaI restriction sites. Downstream from the ApaI site, and before the gus initiating ATG codon, there are two unique sites (SpeI and BglII) that can be used for engineering constructs.
The 3Ј region from pac was obtained by PCR and cloned starting at the SacII restriction site (BamHI site was introduced upstream for convenience). The stop codon of the pac gene was removed and an XbaI site introduced. The BamHI/XbaI pac fragment replaced the cat gene within the previous constructions to obtain pMD2pac and pTG394pac (Figure 2a ).
These plasmids were digested with SacII and BglII to obtain 3Ј pac-2A and 3Ј pac-⌬1D2A fragments that were inserted in vector pLPIT (Figure 2b ) digested in the same way. Resulting vectors are putative tricistronic constructions pLP-2A-XIT and pLP-⌬1D2A-XIT (Figure 2c ). These putative tricistronic constructions contain two genes and a small polylinker free (with unique BglII and SalI restriction sites) for cloning the second gene downstream 2A or ⌬1D2A. Before the SalI site, there is a stop codon in the polylinker (in frame with 2A sequence) delimiting a short peptide (predicted sequence: Pro-Phe-Phe-Phe-Thr-SerArg-Ser-Glu-Leu-Leu).
IRES within these constructs were removed (digesting with BglII and NcoI and blunting the ends with Klenow fragment) during the production of the bicistronic vectors pLP-2A-T and pLP-⌬1D2A-T (Figure 2d ). The NcoI site is reformed after ligation and can be used to remove the HSV1tk gene.
Tricistronic vectors were constructed as follows. EGFP gene was excised from pEGFP-N1 (Clontech, Palo Alto, CA, USA) with BamHI and HpaI and inserted into pBabepuro digested with BamHI and SnaBI. This plasmid was then digested with BamHI and SalI, and the resulting EGFP fragment ligated into plasmid pLT-⌬1D2A-XIT (Figure 2c ). Finally, this construct was cleaved with NcoI and the resulting fragment containing the EGFP-IRES sequence was inserted into plasmid pLP-⌬1D2A-T (Figure 2d ) giving rise to the construct pLP-⌬1D2A-GIT (Figure 2c) .
The vector pLPT (Figure 2e ) contains a direct fusion between pac and HSV1tk genes in phase. Plasmid pLP-⌬1D2A-XIT was digested with SpeI and XbaI and the restriction fragment containing the pac sequences purified. This fragment was ligated into plasmid pLP-2A-T restricted with SpeI and dephosphorylated with alkaline phosphatase, producing plasmid pLPT. The amino acid sequence between pac and HSV1tk is, therefore, Ala-SerSer-Arg-Ser-Met (Ala being the last pac-derived amino acid and Met the first HSV1tk-derived amino acid).
Vector LPX (Figure 2f ) was obtained deleting the SV40 promoter (SalI/HindIII) and the polylinker (BamHI/EcoRI) from pBabepuro, and introducing in the ClaI site, the polylinker from plasmid pCla 12, 24 also digested with ClaI.
The retroviral plasmid pLPIT (Figure 2b ) was derived from pBabepuro deleting the SV40 promoter (SalI/HindIII) and inserting IRES-HSV1tk cassette downstream of the pac gene via the ClaI site using the adaptor plasmid pCla 12.
Finally, vector pLTSP ( Figure 2g ) was constructed introducing the HSV1tk gene (excised via BamHI and XhoI from pTK) into the pBabepuro polylinker. Plasmid pTK was obtained deleting IRES from pSXLC-TK with enzymes XbaI and NcoI. In pTK and pLTSP, the HSV1tk gene has an initial ATG codon in a context (AGCATGG) similar to the consensus Kozak sequence.
Cell culture
Murine fibroblasts NIH/3T3, ecotropic packaging cell line ⌿CRE and amphotropic packaging cell line ⌿CRIP were grown in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% heat inactivated newborn calf serum. Human glioma cell line Hs 683 was grown in DMEM supplemented with 10% heat inacti-vated fetal calf serum. All cells were cultured at 37°C, 7% CO 2 and 97% relative humidity.
Transfection, infection and titration Producer cells were prepared by the transfection of ecotropic packaging ⌿CRE cells, and subsequently using the supernatant to infect amphotropic packaging ⌿CRIP cells according to a previously described method.
14 Transfected ⌿CRE cells and infected ⌿CRIP cells were selected in 2 g/ml puromycin and colonies obtained were pooled.
To determine efficiency of transfection 48 h after transfection, cells were split 1:10 and cultured in 2 g/ml puromycin. Resistant colonies were counted and results expressed as number of colonies per microgram DNA (the number of cells when selection was initiated was 10 6 ).
14 Titers were estimated by infecting NIH/3T3 cells as described previously. 25 Each supernatant was tested once.
Retroviral infection of Hs 683 cells
Hs 683 human glioma cells (5 × 10 3 ) were infected in a 60-mm plate with 1.2 × 10 6 retrovirus in 1 ml of culture medium with 8 g/ml of polybrene for 5 h. After that, another 0.5 ml of medium were added and cells were cultured for 48 h, before being split in two plates, one with 2 g/ml of puromycin selection and the other without selection. Resulting populations were used for subsequent experiments, after 10 days in the first case and 3 days in the second.
GCV sensitivity
Cells were seeded (5 × 10 3 per well) in a 96-well plate. Following 24 h incubation, increasing GCV concentrations were added in a final volume of 200 l of normal medium. Two days later, the percentage of surviving cells was determined to evaluate GCV sensitivity. Cells were fixed with 12% glutaraldehyde, stained with 0.05% methylene blue and eluted in 0.33 N HCl. Absorbance at 630 nm was determined in a MR 5000 microplate reader (Dynatech, West Sussex, UK). Assays were performed by triplicate and the estimated mean value with standard deviations presented in survival curves. Cells grown without GCV were considered as 100% cell survival. In these conditions, it is not unusual to obtain survival values higher in the low-concentration drug wells than in the samples without the drug of a particular curve.
Western blotting
Retrovirus producer cells were sonicated and total protein concentration was determined by BCA Protein Assay (Pierce, Rockford, USA). Proteins were analyzed by 12% SDS-PAGE and electroblotted on to a nylon membrane. The membrane was blocked and incubated with a 1:2000 dilution of anti-rHSV1TK polyclonal antiserum. After extensive washing, the membrane was incubated with a 1:10 000 dilution of HRP labelled anti-rabbit antibody. The blot was washed again and the distribution of HRPlabelled anti-rabbit antibody determined using the Enhanced ChemiLuminiscence system (Amersham, Little Chalfont, UK). The signal were imaged by 10-min exposure.
Flow cytometry ⌿CRIP cells were infected with viruses released from ⌿CRE transfected cells with tricistronic EGFP containing vector. These ⌿CRIP-infected cells were selected with 2 g/ml of puromycin for 1 month. Cells were trypsinized, resuspended in DMEM supplemented with 1% heat inactivated newborn calf serum and analyzed by cytometry with EPICS Profile II Analyzer (Coulter Electronics, Hialeah, FL, USA).
